Afib.no workshop – Exercise and AF, April 12, 2018, at Professorboligen, University of Oslo
The workshop on Exercise and AF brought together 37 AF researchers at Professorboligen, University of Oslo, April 12, in beautiful spring weather.
Keynote speaker, André la Gerche, came all the way from Melbourne, Australia, and gave an excellent talk on the topic: Physical activity, exercise and atrial fibrillation – Current evidence and future opportunities. Bjarne Martens Nes told us the exciting story about the development of “PAI – Physical Activity Index” developed by Ulrik Wisløff’s group, CERG, at NTNU in Trondheim. In addition, Marit Aarønæs, Bente Morseth, Trygve Berge and Erik Ekker Solberg gave talks on AF and exercise-related topics.
We are thrilled to see that our network members have such great interest in the relationship between AF and exercise. As you know, there is ongoing research activity within this field in our network, and members with an particular interest also had the time to meet during the workshop to plan collaborations within afib.no. We look forward to hearing more about the collaboration in the future!
Afib.no 2017 – First Annual Meeting, October 19-20, 2017 at Lysebu, Oslo
We are excited to announce that the first annual meeting of afib.no was a success – bringing together 48 atrial fibrillation researchers from Norway, Denmark and the Netherlands on October 19-20, 2017 at Lysebu, Oslo.
Professor of cardiac arrhythmias and clinical electrophysiologist, Jesper Hastrup Svendsen, from Rigshospitalet, Copenhagen University Hospital and the University of Copenhagen, Denmark, presented the large ongoing LOOP study, a randomized study investigating the health benefits and cost-effectiveness of implantable loop recorders as a screening tool for atrial fibrillation to prevent stroke in patients with risk factors for stroke.
Associate Professor and Clinical Director Michiel Rienstra, Department of Cardiology, University Medical Center Groningen (UMCG), the Netherlands, presented preliminary results from the RACE 3 trial, a randomized trial investigating routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure.
Furthermore, a total of 23 researchers from different groups in Norway presented their research projects and results, covering many AF research areas such as epidemiology, health registries & population-based studies, genetics, biomarkers, echocardiography, and clinical studies.
Save the dates for afib.no 2018, which will be held on September 27-28, 2018! See you in Oslo!